CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Frontage Holdings Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Frontage Holdings Corp
700 Pennsylvania Dr
Phone: (610) 232-0100p:610 232-0100 Exton, PA  19341-1129  United States Ticker: 15211521
Business Summary
Frontage Holdings Corporation is a holding company. The Company provides laboratory and related services to pharmaceutical and agrochemical companies as well as bioequivalence clinical and chemical services. The Company has two main divisions: Global Drug Discovery & Development Services and Global Laboratory Services. The Global Drug Discovery & Development Services division includes Drug Development Unit, Drug Discovery Unit and Pharmaceutical Product Development Unit. The Global Laboratory Services division offers laboratory testing support for clients involved in drug development. Its Global Laboratory Services encompass regulated and non-regulated bioanalysis (both small and large molecules), biomarkers, genomics, manufacturing and controls analytical testing, and central laboratory services. The Company's segments include North America and Europe, and PRC. The North America and Europe segment includes United States, Canada and Europe. The PRC segment includes China.
(Source: 10KSB40)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
8071 Medical laboratories
8734 Testing laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board LiSong 66 1/3/2023 2/10/2021
Co-Chief Executive Officer ZhongpingLin 61 1/6/2025 1/1/2017
Co-Chief Executive Officer ZhangWentao 56 1/6/2025 1/6/2025
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Acme Biosciences, Inc. 3941 E Bayshore Rd Palo Alto California United States
Experimur LLC 4045 South Morgan Street Chicago IL United States
Concord Biosciences, LLC 10845 Wellness Way Concord OH United States
Nucro-Technics, Inc. 2000 Ellesmere Rd Scarborough ON Canada
Frontage Laboratories Inc 700 Pennsylvania Drive EXTON PA United States

Business Names
Business Name
1521
Acme Biosciences, Inc.
Concord Biosciences, LLC
7 additional Business Names available in full report.

General Information
Number of Employees: 1,657 (As of 6/30/2024)
Outstanding Shares: 2,026,018,908 (As of 6/30/2024)
Stock Exchange: HKG
Fax Number: (610) 232-0101


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, February 2, 2025